Skip to main content
Fluorouracil

Fluorouracil

MedicationWikipedia

Search complete. 55 mentions across 15 episodes found for "Fluorouracil".

Sep 18, 2026

Ami GreeneGUEST
25:21
So nearly all treated lesions resolved or flattened, even in patients on EGFR inhibitors and other immune-modulating drugs.
Ami GreeneGUEST
25:29
With the understanding that this is a small four-patient case series, the authors position it as a cheaper, more accessible alternative to intralesional 5-FU or methotrexate and may be a reasonable treatment option for patients.
Ami GreeneGUEST
25:42
So I have utilized intralesional triamcinolone for eruptive keratoacanthomas, eruptive keratoacanthomatous type squames on the lower legs.
Ami GreeneGUEST
25:51
I sometimes will even alternate it with 5-FU or combine it with 5-FU.
Ami GreeneGUEST
25:55
So I do think a multi-modality approach, almost oftentimes non-surgical approach for these patients who have multiple squamous cells on the lower legs is something to consider.
Ami GreeneGUEST
26:05
What are your thoughts?
Ashley WysongGUEST
26:48
And those patients I'll kind of log is my first go to if I really feel like it's inflammatory and reactive and that's helpful.
Ashley WysongGUEST
26:54
Right.
Eric PetersonHOST
22:07
So, He'd been through about seven years of treatment without durable improvement.
Eric PetersonHOST
22:12
On January 2023, he had had by then 24 PDL sessions of pulse dilator, 10 fractional non-ablative 1550 nanometer treatments, and 14 rounds of interlesional 5FU, and still incomplete response.
Eric PetersonHOST
22:26
Then in January of 2024, they added a neuromodulator, essentially just targeting the masseters as well as the platysma at 18 units per masseter and 24 units per platysmal side.
Eric PetersonHOST
22:35
And this was repeated every three to six months over six total sessions.
Ekta YadavHOST
57:51
Mm.
Carl ThornfeldtGUEST
57:51
And so, uh, found that the azelaic acid not only was very potent for anti-inflammatory, but it was also broad-spectrum anti-inflammatory, also broad-spectrum antimicrobial, was also prevented metaplasia that occurred, and even as a drug delivery agent for 5-FU.
Carl ThornfeldtGUEST
58:07
We were able to turn down the incidence of contact reactions and improve the killing of actinic keratoses, particularly hypertrophic actinic keratoses, uh, using the azelaic acid as a carrier for 5-FU.
Carl ThornfeldtGUEST
58:19
So I had a number of patents with, uh, azelaic acid, including the original patents for rosacea, seborrheic dermatitis, and actinic keratoses.
Ekta YadavHOST
58:27
Wow.
Brendan GallagherHOST
40:23
what are your thoughts on get root canal so
Serv WahanGUEST
40:24
i think car noise and like all that other stuff is the older kind of things right the 5fu i've done that so you just take some new gauze right and you 5fu is like an ointment It looks like, you know, something you put on your jock or something, right? You just squeeze it out and like, just on your gloved hand and just like coat the new guys and you just pack it in there and leave a little tail and make sure it's radio opaque.
Serv WahanGUEST
40:50
Right.
Serv WahanGUEST
40:52
And you take it out the next day.
Serv WahanGUEST
40:59
Yeah.
Serv WahanGUEST
41:00
I had a patient, I did that too.
Serv WahanGUEST
41:02
And they're like, They didn't show up for like three days because they missed some appointment and like the kid was somewhere else and like, all right.
Serv WahanGUEST
41:09
So he was like three days out.
VivekHOST
10:44
So what do we do with systemic therapy? The first real progress, other than sort of single-agent therapies and other sort of platinum combinations, was the EXTREME regimen, the EXTREME trial published in the England Journal of Medicine 2008.
VivekHOST
10:58
And this added cetuximab to a platinum and 5-FU.
VivekHOST
11:02
If you remember our induction episode, that TAX324 study that looked at dosataxol, platinum, 5-FU for induction, and that beat platinum 5-FU.
VivekHOST
11:13
When you remember that in a prior randomized trial, but then further studies really showed that induction didn't improve overall survival, which is why you don't really see that.
VivekHOST
11:20
That's how this backbone was created.
VivekHOST
11:21
That platinum 5-FU was used in induction, also used in the metastatic setting.
VivekHOST
11:26
And the idea was let's add that EGFR inhibitor cetuximab to that.
VivekHOST
11:30
And there was an improved overall survival.
Tim BrownHOST
4:34
So, uh, what's really cool about, uh, about anal cancer and sort of the history of it is that this is really the first cancer that had organ preservation emerge as a standard approach to treatment, and this really all emerged in the 1970s, Norman Nigro at Wayne State.
Tim BrownHOST
4:49
What he did was he w- was treating patients with 5-FU and mitomycin C and combining that with 30 Grays of radiation, and he noticed a pattern very early on.
Tim BrownHOST
4:59
The first three patients that he treated with it ended up having a complete response at surgery.
Nicholas HornsteinHOST
5:04
Mm-hmm.
Tim BrownHOST
5:05
So at the time, they were still doing the surgery as a matter of s- of standard of care, and when he put patients through this protocol, they were having complete responses.
Tim BrownHOST
5:13
He expanded this protocol, enrolled about a dozen patients on the study, and from that emerged what is now known as the Nigro protocol, which is basically five weeks of radiation, uh, two cycles of 5-FU and, uh, mitomycin C, uh, more or less.
Tim BrownHOST
5:29
We, we use capecitabine now, uh, in sort of continuous dosing, two doses of mitomycin C, first week and, um, fourth week.
Nicholas HornsteinHOST
5:37
Really nice.
KatrinaHOST
23:55
Not the full Fearnox.
KatrinaHOST
23:57
I guess just the full Fox, because now I'm just on 5FU.
KatrinaHOST
24:01
I'm saying chemo terms.
KatrinaHOST
24:05
All those are names of chemo.
Jill CarnahanGUEST
12:25
And you think back, this is gonna make perfect sense to you.
Jill CarnahanGUEST
12:27
So I was going along eating gluten, didn't know I have silent celiac, and then ga- cancer, and three of the drugs, Cytoxan, 5-FU, and Doxorubicin.
Jill CarnahanGUEST
12:36
And the Cytoxan literally works by creating a more permeable gut.
Darshan ShahHOST
12:40
Right.
John McGraneHOST
13:44
Well, tell us more.
Mohini VarugheseGUEST
13:46
So mitomycin 5-FU, BC 2001 regime.
Mohini VarugheseGUEST
13:50
You've got Beacon, carbidine, nicotinamide.
Mohini VarugheseGUEST
13:53
But the most widely used regime actually is based on the Christie Phase 2 data, which is weekly gemcitabine.
John McGraneHOST
14:24
We don't have the weekly gem at the moment.
John McGraneHOST
14:26
Yeah, but it'd be easy to give.
John McGraneHOST
14:28
For some reason, we've stuck with mitomycin and 5-FU and with carbogen and nicotinamide for those who are not eligible.
John McGraneHOST
14:35
I wouldn't be afraid of giving gemcitabine.
speaker_0HOST
16:31
Mm-hmm.
speaker_1GUEST
16:31
And the primary power tool mentioned in the literature is a drug called 5-fluorouracil or 5-FU.
speaker_0HOST
16:36
Wait a minute, 5-FU.
speaker_0HOST
16:39
I recognize that name.
speaker_0HOST
16:41
Isn't that a chemotherapy drug?
speaker_0HOST
17:12
Okay, so the fibroblasts are the bricklayers.
speaker_1GUEST
17:14
Right.
speaker_1GUEST
17:15
5-FU is an antimetabolic agent, which means it interrupts cell division.

5 more episodes mention Fluorouracil.

Create an account to see the whole feed, search across every transcript, and follow the entities you care about.

We value your privacy

We use cookies to understand how you use our platform and to improve your experience. Click “Accept All” to consent, or “Decline non-essential” to opt out of non-essential cookies. Read our Privacy Policy.